Imugene CEO Leslie Chong Resigns
Key points
- Leslie Chong stepping down as CEO and Managing Director after 11 years
- Resignation due to personal reasons
- Board thanks Chong for her leadership and contributions
- New leadership search initiated immediately
Full summary
Imugene Limited (ASX:IMU) announced that Leslie Chong, Managing Director and Chief Executive Officer, will step down from her position for personal reasons, effective immediately. Chong has been with the company since 2015 and has been instrumental in advancing Imugene's strategic and clinical development. The board expressed gratitude for her leadership and significant contributions. A search for new leadership has commenced, with the senior leadership team reporting to the Executive Chairman in the interim.
Summary generated by a large language model. Please interpret with care.